Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Thoracic Surgery ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Epidemiologic trends and geographic distribution of esophageal cancer in Canada: A national population-based study.Cancer Med. 2020; 9: 401-417
- Trends in esophageal adenocarcinoma incidence and mortality.Cancer. 2013; 119: 1149-1158
- ACG Clinical Guideline: Diagnosis and management of Barrett’s esophagus.Am J Gastroenterol. 2016; 111: 30-50
- Epidemiology of Barrett’s esophagus and esophageal adenocarcinoma - implications for screening and surveillance.Gastrointest Endosc Clin N Am. 2021; 31: 1-26
- Esophageal carcinoma.N Engl J Med. 2014; 371: 2499-2509
- Guideline on screening for esophageal adenocarcinoma in patients with chronic gastroesophageal reflux disease.Can Med Assoc J. 2020; 192: E768-E777
- Esophageal cancer: An updated Surveillance Epidemiology and End Results database analysis.World J Oncol. 2020; 11: 55-64
- Detection of intestinal metaplasia in Barrett’s esophagus: an observational comparator study suggests the need for a minimum of eight biopsies.Am J Gastroenterol. 2007; 102: 1154-1161
- Barrett’s esophagus: a comprehensive and contemporary review for pathologists.Am J Surg Pathol. 2016; 40: e45-e66
- The epidemiology of esophageal adenocarcinoma.Gastroenterology. 2018; 154: 390-405
- The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis.Gut. 2012; 61: 970-976
- Incidence of esophageal adenocarcinoma in Barrett’s esophagus with low-grade dysplasia: a systematic review and meta-analysis.Gastrointest Endosc. 2014; 79 (e4): 897-909
- Incidence of esophageal adenocarcinoma in patients with Barrett’s esophagus and high-grade dysplasia: a meta-analysis.Gastrointest Endosc. 2008; 67: 394-398
- Barrett’s esophagus and Barrett’s-related dysplasia.Mod Pathol. 2003; 16: 316-324
- The changing role of the pathologist in the management of Barrett’s oesophagus.Histopathology. 2014; 65: 441-455
- Chronic peptic ulcers of the œsophagus and ‘œsophagitis.Br J Surg. 1950; 38: 175-182
- Definition, derivation, and diagnosis of Barrett’s esophagus: pathological perspectives.in: Jansen M. Wright N.A. Stem cells, Pre-neoplasia, and early cancer of the Upper gastrointestinal tract. Springer International Publishing, Switzerland2016: 111-136
- The histologic spectrum of Barrett’s esophagus.N Engl J Med. 1976; 295: 476-480
- Intestinal metaplasia in Barrett’s oesophagus may be an epiphenomenon rather than a preneoplastic condition, and CDX2-positive cardiac-type epithelium is associated with minute Barrett’s tumour.Histopathology. 2015; 66: 201-214
- Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma.Hum Pathol. 2009; 40: 65-74
- Metaplasia and transdifferentiation: from pure biology to the clinic.Nat Rev Mol Cell Biol. 2007; 8: 369-378
- The cell of origin for Barrett’s esophagus.Science. 2021; 373: 737-738
- Distribution of cytokeratin markers in Barrett’s specialized columnar epithelium.Gastroenterology. 1997; 112: 760-765
- Origin of pancreatic ductal adenocarcinoma from atypical flat lesions: a comparative study in transgenic mice and human tissues.J Pathol. 2012; 226: 723-734
- The human squamous oesophagus has widespread capacity for clonal expansion from cells at diverse stages of differentiation.Gut. 2015; 64: 11-19
- Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett’s esophagus.Dis Esophagus. 2008; 21: 43-50
- Columnar metaplasia in a surgical mouse model of gastro-esophageal reflux disease is not derived from bone marrow-derived cell.Cancer Sci. 2013; 104: 1154-1161
- Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett’s oesophagus.Gut. 2008; 57: 1041-1048
- Single cell RNA-seq reveals profound transcriptional similarity between Barrett’s oesophagus and oesophageal submucosal glands.Nat Commun. 2018; 9: 4261
- Molecular phenotyping reveals the identity of Barrett’s esophagus and its malignant transition.Science. 2021; 373: 760-767
- Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications.Hum Pathol. 1983; 14: 931-968
- What makes an expert Barrett’s histopathologist?.in: Jansen M. Wright N.A. Stem cells, Pre-neoplasia, and early cancer of the Upper gastrointestinal tract. Springer International Publishing, Switzerland2016: 137-159
- Histopathology of Barrett’s esophagus and early-stage esophageal adenocarcinoma: an updated review.Gastrointest Disord. 2019; 1: 147-163
- The modern management of Barrett’s oesophagus and related neoplasia: role of pathology.Histopathology. 2021; 78: 18-38
- Esophageal adenocarcinoma with any component of signet ring cells portends poor prognosis and response to neoadjuvant therapy.J Thorac Cardiovasc Surg. 2021; 162: 1404-1412
- Signet ring cells in esophageal adenocarcinoma predict poor response to preoperative chemoradiation.Ann Thorac Surg. 2014; 98: 1064-1071
- 8th edition AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice.Ann Cardiothorac Surg. 2017; 6: 119-130
- Examination of surgical specimens of the esophagus.Arch Pathol Lab Med. 2015; 139: 1446-1454
- A 14-year study of 398 esophageal adenocarcinomas diagnosed among 156,256 EGDs performed at two large hospitals: an inlet patch is proposed as a significant risk factor for proximal esophageal adenocarcinoma.Dig Dis Sci. 2018; 63: 452-465
- Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and of the proximal stomach.Am J Surg Pathol. 2002; 26: 1213-1221
- Identical cytokeratin expression pattern CK7+/CK20- in esophageal and cardiac cancer: etiopathological and clinical implications.Mod Pathol. 2004; 17: 49-55
- Treatment of locally advanced esophageal carcinoma: ASCO Guideline.J Clin Oncol. 2020; 38: 2677-2694
- Endoscopic mucosal resection (EMR) in Barrett’s esophagus associated neoplasia: recommendations for pathological evaluation and reporting.Can J Pathol. 2015; 7: 25-36
- AGA clinical practice update on endoscopic treatment of Barrett’s esophagus with dysplasia and/or early cancer: expert review.Gastroenterology. 2020; 158: 760-769
- Pathological assessment of endoscopic resections of the gastrointestinal tract: a comprehensive clinicopathologic review.Mod Pathol. 2020; 33: 986-1006
- AGA clinical practice update on the utility of endoscopic submucosal dissection in T1b esophageal cancer: expert review.Clin Gastroenterol Hepatol. 2019; 17: 2161-2166
- The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns.Surg Endosc. 2015; 29: 1888-1896
- Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion.Clin Gastroenterol Hepatol. 2013; 11: 630-635
- Depth of submucosal tumor infiltration and its relevance in lymphatic metastasis formation for T1b squamous cell and adenocarcinomas of the esophagus.J Gastrointest Surg. 2014; 18: 242-249
- Lymph node metastasis in early esophageal adenocarcinoma.Ann Surg. 2011; 254: 731-737
- Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.Cancer. 2008; 112: 1020-1027
- Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma.Clin Gastroenterol Hepatol. 2010; 8: 248-253
- Measuring depth of invasion of submucosa – invasive adenocarcinoma in oesophageal endoscopic specimens: how good are we?.Histopathology. 2022; 80: 420-429
- The risk of lymph node metastases in patients with high grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systematic review.Am J Gastroenterol. 2012; 107: 850-863
- Early Barrett’s carcinoma: the depth of infiltration of the tumour correlates with the degree of differentiation, the incidence of lymphatic vessel and venous invasion.Virchows Archiv. 2010; 456: 609-614
- Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.Am J Surg Pathol. 2011; 35: 1045-1053
- Clinical significance of the duplicated muscularis mucosae in Barrett esophagus-related superficial adenocarcinoma.Am J Surg Pathol. 2011; 35: 697-700
- Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues.Am J Clin Pathol. 2008; 129: 252-262
- The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation.Cancer. 2006; 107: 1467-1474
- Pathologic complete response is an independent predictor of improved survival following neoadjuvant chemoradiation for esophageal adenocarcinoma.J Gastrointest Surg. 2016; 20: 1541-1546
- Prognostic significance of histopathological tumor regression after neoadjuvant chemotherapy in esophageal adenocarcinomas.Mod Pathol. 2009; 22: 1555-1563
- Prognostic value of neoadjuvant treatment response in locally advanced esophageal adenocarcinoma.J Thorac Cardiovasc Surg. 2019; 157: 1682-1693
- Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations.Cancer. 1994; 73: 2680-2686
- Tumor regression grading of gastrointestinal cancers after neoadjuvant therapy.Virchows Archiv. 2018; 472: 175-186
- Prognostic value of tumor regression grade based on Ryan score in squamous cell carcinoma and adenocarcinoma of esophagus.Ann Surg Oncol. 2020; 27: 1241-1247
- Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma.Br J Surg. 2017; 104: 1816-1828
- Assessment of tumor regression of esophageal adenocarcinomas after neoadjuvant chemotherapy: comparison of 2 commonly used scoring approaches.Am J Surg Pathol. 2014; 38: 1551-1556
- Prevalence and significance of prominent mucin pools in the esophagus post neoadjuvant chemoradiotherapy for Barrett’s-associated adenocarcinoma.Am J Surg Pathol. 2006; 30: 28-35
- Diagnostic accuracy and utility of intraoperative microscopic margin analysis of gastric and esophageal adenocarcinoma.Ann Surg Oncol. 2014; 21: 2580-2586
- Systematic review and meta-analysis of the influence of circumferential resection margin involvement on survival in patients with operable oesophageal cancer.Br J Surg. 2013; 100: 456-464
- Impact of peritumoral and intratumoral budding in esophageal adenocarcinomas.Hum Pathol. 2016; 52: 1-8
- Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma.Mod Pathol. 2014; 27: 1578-1589
- Tumor budding assessed according to the criteria of the International Tumor Budding Consensus Conference determines prognosis in resected esophageal adenocarcinoma.Virchows Archiv. 2021; 478: 393-400
- Pathologic assessment of endoscopic resection specimens with superficial carcinoma of the esophagus: current practice and practical issues.Ann N Y Acad Sci. 2020; 1482: 130-145
- International multicenter study on the impact of extracapsular lymph node involvement in primary surgery adenocarcinoma of the esophagus on overall survival and staging systems.Ann Surg. 2015; 262: 809-816
- Lymphovascular invasion as a poor prognostic indicator in thoracic esophageal carcinoma: a systematic review and meta-analysis.Dis Esophagus. 2019; 32: doy083
- Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Ann Oncol. 2016; 27: v50-v57
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.Lancet. 2010; 376: 687-697
- HER2 amplification, overexpression and score criteria in esophageal adenocarcinoma.Mod Pathol. 2011; 24: 899-907
- Association of HER2/ErbB2 expression and gene amplification with pathologic features and prognosis in esophageal adenocarcinomas.Clin Cancer Res. 2012; 18: 546-554
- HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and American Society of Clinical Oncology.Am J Clin Pathol. 2016; 146: 647-669
Article info
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
